Lukas Cyganek - Publications

Cardiolipin remodeling in diabetic cardiomyopathy: Spotlight on ALCAT1.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: March 24, 2026

Improved Surface Properties and Enhanced Cell Adhesion on Poly-ε-Caprolactone for Heart Valve Tissue Engineering Applications via H2-N2 Plasma Treatment.

Journal: International journal of molecular sciences

Published: January 07, 2026

Variant U1 snRNAs contribute to cell cycle and differentiation control of human iPS cells.

Journal: Nature communications

Published: September 02, 2025

Promoting differentiation of human-induced pluripotent stem cells into sinoatrial node-like cells through programmed regulation of AMPK signalling pathway.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: July 29, 2025

Roles of Catecholamines and Inflammation in Endothelial Dysfunction: a Study Using Takotsubo Syndrome Patient-specific hiPSC-ECs.

Journal: Stem cell reviews and reports

Published: June 05, 2025

Phenotypes in Brugada syndrome with different genotypes triggered by fever or inflammation using gene-edited iPSCs.

Journal: Stem cell research & therapy

Published: May 08, 2025

Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy.

Journal: Cell

Published: April 14, 2025

SLC4A3-related short QT syndrome assessed in human induced pluripotent stem cell-derived cardiomyocytes: mechanisms of ventricular arrhythmia and sudden cardiac death.

Journal: European heart journal

Published: December 19, 2024

Enhancing KLF15 activity in cardiomyocytes: a novel approach to prevent pathological reprogramming and fibrosis via nuclease-deficient dCas9VPR.

Journal: Signal transduction and targeted therapy

Published: December 10, 2024

Exosomal mir-126-3p derived from endothelial cells induces ion channel dysfunction by targeting RGS3 signaling in cardiomyocytes: a novel mechanism in Takotsubo cardiomyopathy.

Journal: Stem cell research & therapy

Published: November 06, 2024

Generation of a heterozygous Calsequestrin 2 F189L iPSC line (UMGi158-B) by CRISPR/Cas9 genome editing to investigate the cardiac pathophysiology of Takotsubo Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia.

Journal: Stem cell research

Published: July 30, 2024

CardioMEA: comprehensive data analysis platform for studying cardiac diseases and drug responses.

Journal: Frontiers in physiology

Published: July 28, 2024